TFM
ASND icon

TFC Financial Management’s Ascendis Pharma A/S ASND Stock Holding History

TFC Financial Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-70
Closed -$7K – 525
2022
Q2 		$7K Hold
70
– – ﹤0.01% 325
2022
Q1 		$8K Hold
70
– – ﹤0.01% 320
2021
Q4 		$9K Hold
70
– – ﹤0.01% 346
2021
Q3 		$11K Hold
70
– – ﹤0.01% 322
2021
Q2 		$9K Buy
+70
New +$9.33K ﹤0.01% 327

Other funds holding ASND

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

TFC Financial Management's ASND Position: Q3 2022 in Review

TFC Financial Management sold out of Ascendis Pharma A/S (ASND) in Q3 2022, closing a stake of 70 shares — an estimated $7K sold.

TFC Financial Management first reported a position in ASND in Q2 2021 and held it in 5 quarters. The position peaked at $11K in Q3 2021. 183 funds tracked by Wall St. Rank hold ASND as of Q3 2022.

  • TFC Financial Management reported no remaining Ascendis Pharma A/S position as of Q3 2022 after selling out during the quarter.
  • TFC Financial Management sold 70 Ascendis Pharma A/S shares in Q3 2022, an estimated $7K.
  • TFC Financial Management first reported a position in Ascendis Pharma A/S in Q2 2021 and held it in 5 quarters.
  • TFC Financial Management's Ascendis Pharma A/S position peaked at $11K in Q3 2021.
  • 183 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2022.

Based on TFC Financial Management's 13F filing for Q3 2022, filed 21 Oct 2022.